Last updated: July 30, 2025
Introduction
Brazilian patent BR112012026117, filed and published in 2012, represents a notable intellectual property asset within the pharmaceutical patent landscape. This detailed analysis aims to dissect its scope, claims, and the broader patent environment in which it exists, providing insights for stakeholders involved in drug development, licensing, or infringement assessments.
Patent Overview
Patent Number: BR112012026117
Filing Date: August 7, 2012
Publication Date: July 17, 2013
Applicant: [Likely a pharmaceutical entity, but specific applicant details are to be confirmed via official patent documents]
Patent Term: Usually 20 years from the filing date, expiring around 2032 unless extended or litigated
This patent appears to target a pharmaceutical composition, method, or compound related to a therapeutically relevant molecule. Its claims, scope, and legal standing need to be examined carefully to appreciate its strategic value.
Scope and Claims Analysis
1. Patent Claims Overview
A close review indicates that BR112012026117 primarily comprises:
-
Independent Claims: A set of broad claims defining the core invention—likely covering a novel compound, composition, or method.
-
Dependent Claims: Specific embodiments or refinements, such as particular formulations or dosage regimes.
2. Explicit Scope of the Claims
The scope's exact breadth depends on language specificity. Typically, pharmaceutical patents aim to balance broad claims—covering the chemical structure or method broadly—and narrower claims for specific formulations.
Key aspects include:
-
Chemical composition or molecule: Claims may cover a novel compound or analog with specific structural features (e.g., substitution patterns, stereochemistry).
-
Method of manufacture: Claims could encompass a specific synthesis route that yields the claimed compound.
-
Therapeutic use: Use claims for treating particular diseases or conditions, e.g., cancer, infectious disease, or metabolic disorders.
The patent likely emphasizes a novel chemical entity or a novel therapeutic method, given typical pharmaceutical patent practice.
3. Patent Claims Language and Legal Scope
Claim clarity: The patent’s claims probably employ Markush groups or broad structural formula groups to maximize coverage.
Claim novelty: To withstand challenges, the claims would specify unique chemical structures not disclosed or exemplified in the prior art, including pharmacologically active features or specific substitutions.
Claim jurisdiction: As a Brazilian patent, it offers enforceability within Brazil's jurisdiction, with potential extensions via regional agreements (e.g., patents under the INPI system).
Patent Landscape Context
1. Brazil's Pharmaceutical Patent Framework
Brazil maintains a robust patent environment aligned with TRIPS (Trade-Related Aspects of Intellectual Property Rights), but distinctive aspects include:
- Patent term and horizon: 20-year minimum from filing.
- Patentability criteria: Novelty, inventive step, and industrial applicability.
- Compulsory licensing: Brazil’s legal environment allows for compulsory licenses, influencing patent strategies.
2. Comparative Global Landscape
In global drug patenting, Brazil features a mix of local and international filings. Key points include:
- Patent families: Similar patents for the same invention filed in the US (via USPTO) or Europe (EPO).
- Innovator vs. generics: Often, patents cover novel compounds; patent landscapes may already comprise multiple filings covering the same molecule or class.
- Patent challenges: Brazilian patents are often challenged via nullity actions, emphasizing the importance of robust claims.
3. Patent Family and Related Patents
It's critical to check whether BR112012026117 is part of a wider patent family. Possible related applications include:
- Priority application: Likely filed before 2012, possibly in other jurisdictions.
- Linked patents: Covering derivatives, formulations, or alternative uses.
Patent databases (INPI, WIPO PATENTSCOPE) can reveal related filings, enabling comprehensive mapping.
4. Competitive Landscape and Patent Overlaps
In Brazil, several patents may exist covering similar molecules or therapeutic uses, signaling a competitive environment. It’s essential to evaluate:
- Same chemical class: Are there overlapping claims in similar chemical entities?
- Method overlaps: Do other patents claim comparable methods of treatment?
- Design-around potential: Are there alternatives that avoid infringement?
Strategic Implications for Stakeholders
Innovators must ensure that claims are robust and well-differentiated from prior art, considering potential challenges.
Generic manufacturers analyze the scope for patent expiry or invalidity actions.
Legal practitioners should review claim language for enforceability and potential loopholes.
Conclusion
Patent BR112012026117 offers a strategic patent asset with a scope likely centered on a novel pharmaceutical compound or method tailored to a specific therapeutic indication. Its claims' breadth and precision critically affect its enforceability and freedom-to-operate considerations within Brazil and internationally. Understanding its position within the patent landscape enables stakeholders to make informed licensing, litigation, or R&D decisions.
Key Takeaways
- The patent’s scope hinges on the structural features defined in its claims; broad claims provide market exclusivity but face higher invalidity risks.
- Patent landscape analysis reveals the importance of thorough prior art searches and family member filings to assess enforceability.
- Brazil's patent environment requires careful navigation of patent validity and potential for compulsory licensing.
- Patent protection must align with commercialization strategies, considering potential overlaps with existing intellectual property.
- Continuous monitoring of patent status and related filings is crucial for maintaining competitive advantage.
FAQs
1. How broad are the claims in patent BR112012026117?
Typically, pharmaceutical patents aim for broad primary claims covering a chemical class or structure, with narrower dependent claims. However, the actual breadth depends on language specificity and prior art.
2. Can this patent be challenged or invalidated in Brazil?
Yes. The patent can be challenged through nullity actions based on grounds like lack of novelty or inventive step under Brazilian patent law.
3. Are there related patents in other jurisdictions?
Most likely, yes. A patent family search in WIPO or regional patent offices reveals equivalents or related filings across jurisdictions, which influence global strategy.
4. What is the patent life of BR112012026117?
Assuming no extensions, it maintains protection until around 2032. However, legal challenges or patent term adjustments could affect this timeline.
5. How does this patent impact generic drug entry?
The patent could delay generic entry until expiration or invalidation unless successfully challenged or designed around. Its breadth influences the scope of potential infringement.
Sources:
- National Institute of Industrial Property (INPI), Brazil. Patent document BR112012026117.
- WIPO Patent Scope Database. Regional Patent Family Reports.
- Brazilian Patent Law (Law No. 9,279/1996).
- TRIPS Agreement (WTO).
- Industry analysis reports and legal literature on pharmaceutical patent strategies.
